Option Care Health Inc ( (OPCH) ) has released its Q2 earnings. Here is a breakdown of the information Option Care Health Inc presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Option Care Health Inc., the largest independent provider of home and alternate site infusion services in the United States, has released its financial results for the second quarter of 2025, showcasing its continued growth and resilience in the healthcare sector.
In the second quarter of 2025, Option Care Health reported a net revenue of $1.416 billion, marking a 15.4% increase from the same period in 2024. Despite a slight decrease in net income to $50.5 million from $53.0 million, the company achieved a 3.3% rise in diluted earnings per share to $0.31. The company also repurchased approximately $50 million of its stock during this period.
Key financial metrics highlighted include an adjusted net income of $67.5 million, up from $64.9 million in the previous year, and an adjusted EBITDA of $114.0 million, reflecting a 5.2% increase. However, cash flow from operations saw a significant drop to $90.3 million compared to $195.7 million in the second quarter of 2024.
Looking forward, Option Care Health has updated its full-year 2025 financial guidance, projecting net revenue between $5.50 billion and $5.65 billion, with adjusted diluted earnings per share expected to range from $1.65 to $1.72. The company anticipates an adjusted EBITDA of $465 million to $475 million and a cash flow from operations of at least $320 million.
Overall, Option Care Health remains committed to delivering strong clinical outcomes and reducing the total cost of care, as it navigates the dynamic healthcare market with strategic growth and operational efficiency.